ω-3 Polyunsaturated Fatty Acid Status Testing in Humans: A Narrative Review of Commercially Available Options
Authors:
Open Access
- 22 March 2024
- journal article
- review article
- Published by Elsevier in The Journal of Nutrition
- Vol. 154 (5) , 1487-1504
Abstract
No abstract availableKeywords
This publication has 185 references indexed in Scilit:
- Another Disappointment for ω-3 Fatty Acid and Dry Eye DiseaseJAMA Ophthalmology, 2022
- Dietary and supplemental long-chain omega-3 fatty acids as moderators of cognitive impairment and Alzheimer’s diseaseEuropean Journal of Nutrition, 2021
- Association Between Achieved ω-3 Fatty Acid Levels and Major Adverse Cardiovascular Outcomes in Patients With High Cardiovascular RiskJAMA Cardiology, 2021
- Effect of High-Dose Omega-3 Fatty Acids vs Corn Oil on Major Adverse Cardiovascular Events in Patients at High Cardiovascular RiskJAMA, 2020
- Interlaboratory Assessment of Dried Blood Spot Fatty Acid CompositionsLipids, 2019
- Evaluation of a Rapid Assessment Questionnaire Using a Biomarker for Dietary Intake of n‐3 Fatty AcidsLipids, 2019
- n‐3 Docosapentaenoic Acid Intake and Relationship with Plasma Long‐Chain n‐3 Fatty Acid Concentrations in the United States: NHANES 2003–2014Lipids, 2019
- Absolute versus relative measures of plasma fatty acids and health outcomes: example of phospholipid omega-3 and omega-6 fatty acids and all-cause mortality in womenEuropean Journal of Nutrition, 2016
- ω-3 Polyunsaturated Fatty Acid Biomarkers and Coronary Heart DiseaseJAMA Internal Medicine, 2016
- Dietary Intake and Cell Membrane Levels of Long-Chain n-3 Polyunsaturated Fatty Acids and the Risk of Primary Cardiac ArrestJAMA, 1995